6640--CTX Immunoassay Random Access Multiplex Analyzer

Solicitation / RFP / RFQ

This document is a solicitation for a CTX Immunoassay Random Access Multiplex Analyzer. The Department of Veterans Affairs, Network Contracting Office 17, is seeking to procure this equipment.

• The primary deliverable is a CTX Immunoassay Random Access Multiplex Analyzer.

• This appears to be a contract award notice, not a solicitation. The award number is 36C25726C0030, with an award amount of $271,076.60, awarded on 02-18-2026 to GOVERNMENT SCIENTIFIC SOURCE INC.

• Not applicable as this is an award notice.

• Not specified in the provided text.

• The document includes information about the contracting office (San Antonio, TX), the Product Service Code (6640), and NAICS Code (334516).

Solicitation / RFP / RFQ

This solicitation is for the procurement of a commercial, fully automated, random-access multiplex immunoassay analyzer system. The system will replace an existing analyzer that has reached the end of its economic lifecycle and is needed to support the detection of autoantibodies and related markers essential for managing connective tissue and immune-mediated diseases, as well as for clinical diagnosis.

• A fully automated, random-access multiplex immunoassay analyzer system.

• FDA approved.

• Capable of testing for total Syphilis (IgG and IgM) and RPR, as well as Anti-Nuclear Antibody (ANA).

• Capable of performing additional assays as needed in the future, including autoimmune, infectious disease, and specialty immunoassay testing.

• Programmable priority testing for STAT samples.

• Must accept CLSI standard specimen tubes.

• Operates on a 110v power supply with an uninterruptible power supply (UPS) included.

• User interface (touchscreen preferred) for programming and operation.

• Integrated functionality to perform and document quality control checks.

• Delivery, installation, and initial operational checks.

• Removal and disposal of the existing end-of-life analyzer.

• Operator training, manuals, and maintenance instructions.

• Contract Type: Not explicitly stated, but implied to be a fixed-price contract based on "firm fixed price" in price submission instructions.

• Period of Performance (POP): Base POP Begin: 02-20-2026, POP End: 05-19-2026.

• Estimated Value: Not stated.

• Proposal Submission: Offers must be submitted electronically via email to the Contracting Officer/Contract Specialist by the specified date and time. Email subject line: "Offer – Immunoassay Random-Access Multiplex Analyzer [Offeror Name]."

• Offer Validity: At least 60 calendar days from the receipt of offers.

• Evaluation Criteria: Lowest Price Technically Acceptable (LPTA) with SDVOSB/VOSB factor and tiebreaker.

  • Technical Acceptability (Acceptable/Unacceptable)
  • SDVOSB/VOSB Participation
  • Price

• Award will be made to the responsible offeror whose offer is technically acceptable, has acceptable SDVOSB/VOSB participation, and offers the lowest total evaluated price.

• Questions Deadline: February 9, 2026, 10:00 AM CST.

• Offer Due Date: February 13, 2026, 10:00 AM CST.

• NAICS Code: 334516 (Analytical Laboratory Instrument Manufacturing).

• Size Standard: 1000 Employees.

• The acquisition is set aside for Small Business (Unrestricted or Set Aside options are presented, but the specific set-aside is not definitively stated in the initial blocks, though evaluation factors heavily favor SDVOSB/VOSB participation).

• FAR 52.212-1, 52.212-3, and 52.212-5 are attached.

• VAAR clauses are incorporated by reference and/or attached.

• Payment will be made via Electronic Funds Transfer through the Tungsten Network.

• Invoices are to be submitted electronically upon delivery.

Solicitation

The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 17, is seeking a commercial, fully automated, random-access multiplex immunoassay analyzer system for the Central Texas Veterans Health Care System (CTVHCS) in Temple, Texas. This acquisition aims to replace an existing end-of-life analyzer and will result in a single firm-fixed-price contract.

The new system must be capable of performing autoimmune, infectious disease, and specialty immunoassay testing on a consolidated platform. Minimum requirements include:

• Programmable STAT/priority testing

• Acceptance of CLSI-standard specimen tubes

• Operation on standard 110-volt power

• Inclusion of an appropriate uninterruptible power supply (UPS)

• Integrated quality control capabilities

• Delivery, installation, initial operational verification

• Removal of the existing analyzer

• Contract Type: Firm-fixed-price

• Acquisition Procedures: FAR Part 12 (Commercial Products and Services) as updated by FAR Revolutionary Overhaul, and FAR Part 15.

• Evaluation Approach: Lowest Price Technically Acceptable (LPTA) best-value approach.

• Technical Acceptability: Pass/fail basis against minimum requirements.

• Award: To the responsible offeror with the lowest total evaluated price among technically acceptable offers, subject to price reasonableness.

• Response Date/Time: 02-13-2026 10:00 CENTRAL TIME, CHICAGO, USA.

• This procurement is UNRESTRICTED. All responsible sources may submit an offer.

• Applicable NAICS Code: 334516 (Analytical Laboratory Instrument Manufacturing).

• Small Business Size Standard: 1,000 employees.

• Offerors must be registered in the System for Award Management (SAM) under the applicable NAICS code prior to award.

• The solicitation and any amendments will be issued electronically via SAM.gov. Interested parties must monitor SAM.gov for updates.

• The place of performance is Department of Veterans Affairs, Central Texas Veterans Health Care System, Laboratory, 1901 Veterans Memorial Dr., Temple TX 76504-7176.